Bryukhovetskiy AS, Bryukhovetskiy IS. Effectiveness of repeated transplantations of hematopoietic stem cells in spinal cord injury. World J Transplant 2015; 5(3): 110-128 [PMID: 26421264 DOI: 10.5500/wjt.v5.i3.110]
Corresponding Author of This Article
Andrey S Bryukhovetskiy, MD, PhD, Professor, NeuroVita Clinic of Restorative and Interventional Neurology and Therapy, 23 Kashirskoye shosse, 115478 Moscow, Russia. neurovitaclinic@gmail.com
Research Domain of This Article
Neurosciences
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Transplant. Sep 24, 2015; 5(3): 110-128 Published online Sep 24, 2015. doi: 10.5500/wjt.v5.i3.110
Table 1 Sex, age, level of injury distribution of patients with traumatic disease of spinal cord (main group)
No. of patients
202 (1008 case histories)
Age
From 19 to 51 yr
Gender
Males - 156, females - 46
Years post injury
Less than 1 yr - 11
From 1 to 5 yr - 144
Over 5 yr - 47
Level of spinal cord injury
Cervical level - 93
Thoracic level - 98
Lumbar level - 11
Type of injury
Complete - 43
Incomplete - 159
No. of transplantations
No less than 20 HSCs and HPs transplantations
Average number of transplanted cells
5.8 × 106
Table 2 Sex, age, level of injury distribution of patients with traumatic disease of spinal cord (control group)
No. of patients
20 (62 case histories)
Age
From 18 to 44 yr
Gender
Males - 13, females - 7
Years post injury
< 1 yr - 6
From 1 to 5 yr - 10
Over 5 yr - 4
Level of spinal cord injury
Cervical level - 14
Thoracic level - 4
Lumbar level - 2
Type
Complete - 12
Incomplete - 8
Table 3 The characteristics and basic differences of the hematopoietic stem cells and hematopoietic precursors preparation from the preparation of hematopoietic stem cells used for bone marrow transplantation
Technique
G-CSF dose
Period of administration (d)
Stimulation regimen
Cell markers
Cryopreservant
Administration of HSCs in blood
10-20 μg/kg
6-7
1 in 24 h
CD34+, CD45+
10%-20% DMSO
HLA DR+, CD38+
Gp130±
Administration of HSC and HPs in CSF
5 μg/kg; double dose at day 4
5
2 in 24 h
CD34+, CD45-
5%-10% DMSO +
HLA DR±, CD38±
polyglucin
Gp130+
Table 4 Clinical symptoms of the complications and side effects in spinal cord injury patients
Symptoms
Stages of research
Control group patients
1 stage
2 stage
3 stage
Increased spasticity
46%
49.9%
54.5%
0
Fever
15%
19%
18.8%
0
Post-puncture headache
11%
14.9%
12.2%
14.9%
High blood pressure
10%
8.1%
14.5%
0
Coordination disturbance
2.3%
1.3%
0
0
Dizziness
2%
3.4%
0
4.2%
Sleepiness
2.1%
1.7%
0
0
Emotional lability
1.6%
1.7%
0
0
Disordered consciousness
1.2%
0.8%
0.8%
0
Meningism
3.7%
2.95%
0.8%
0
Low blood pressure
1.68%
2.95%
5.9%
0
General % of the patients with complications
63.5%
72.9%
75%
19.1%
Citation: Bryukhovetskiy AS, Bryukhovetskiy IS. Effectiveness of repeated transplantations of hematopoietic stem cells in spinal cord injury. World J Transplant 2015; 5(3): 110-128